Quantitative and functional assessment of anti-RhD: A comparative study of non-invasive methods in antenatal prediction of Rh hemolytic disease

Acta Obstetricia et Gynecologica Scandinavica

Volumn 75, Issue 2, 1996, Pages 102-107

  Filbey, Derek ^a   Garner, Stephen F ^b   Hadley, Andrew G ^c   Shepard, Sarah L ^c  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^b North London Blood Transfusion Centre   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Anti D; Chemiluminescence; Hemolytic disease of the newborn (HDN); HLA class II antibodies

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; RHESUS D ANTIBODY; PEPTIDE; RHO(D) ANTIGEN;

ANTIBODY TITER; ARTICLE; CHEMOLUMINESCENCE; CLINICAL PROTOCOL; FEMALE; FETUS; HUMAN; NEWBORN; NEWBORN HEMOLYTIC DISEASE; PREDICTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RHESUS INCOMPATIBILITY; BLOOD GROUP RHESUS SYSTEM; COMPARATIVE STUDY; CYTOLOGY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; METHODOLOGY; MONOCYTE; PREDICTION AND FORECASTING; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDY; STANDARD;

CHEMILUMINESCENT MEASUREMENTS; ERYTHROBLASTOSIS, FETAL; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INFANT, NEWBORN; MONOCYTES; PEPTIDES; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; RH-HR BLOOD-GROUP SYSTEM;

EID: 0029664665     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016349609033299     Document Type: Article

References (20)

1. Tovey LAD. Rh haemolytic disease of the newborn: the role of the laboratory. Med Lab Sci 1982; 39: 297-303.
2. Bowell P, Wainscoat JS, Peto TEA, Gunson HH. Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn. BMJ 1982; 285: 327-9.
3. Nicolaides KH, Rodeck CH. Maternal serum anti-D antibody concentration and assessment of rhesus isoimmunisation. BMJ 1992; 304: 1155-6.
4. Hadley AG, Kumpel BM, Leader KA, Poole GD, Fraser ID. Correlation of the serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn. Br J Haematol 1991; 77: 221-8.
5. Zupanska B, Brojer E, Richards Y, Lenkiewicz B, Seyfried H. Howell P. Serological and immunological characteristics of maternal anti-Rh(D) antibodies in predicting the severity of haemolytic disease of the newborn. Vox Sang 1989, 56: 247-253.
6. Dooren MC, van Kamp IL, Kanhai HH, Gravenhorst JB, von dem Borne AE, Engelfriet CP. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn. Vox Sang 1993; 65: 55-8.
7. Filbey D, Berseus O, Lindeberg S, Wesstrom G. A management programme for Rh alloimmunization during pregnancy. Early Hum Dev 1987; 15: 11-20.
8. Mollison PL, Engelfriet CP, Contreras M. In: Blood transfusion in clinical medicine. 9th Ed, Oxford, UK: Blackwell Scientific Publications. 1993; 565-6.
9. Diamond LK, Allen Jr FH, Thomas Jr WO. Erythroblastosis faetalis. VII. Treatment with exchange transfusion. N Engl J Med 1951; 244: 39-49.
10. Filbey D, Berseus O, Sandstrom B, Wesstrom G. The evaluation of maternal anti-D concentrations during pregnancy. Early Hum Dev 1987; 15: 1-9.
11. Crockford J, Moore BPL. PVP-augmented LISP and DISP Autoanalyzer haemagglutination channels. J Clin Pathol 1979; 32: 845-51.
12. Frazer ID, Tovey GH. Observations on Rh iso-immunization: past, present and future. Clin Haematol 1976; 5: 149-63.
13. Hadley AG, Kumpel BM, Merry AH. The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-Rh(D) antibodies. Clin Lab Haematol 1988; 10: 377-84.
14. Hadley AG, Poole GD, Fraser ID. Predicting the severity of haemolytic disease of the newborn: propective evaluation of the chemiluminescence test. Vox Sang 1992; 63: 2912.
15. Kuijpers RWAM, Dooren MC, von dem Borne AEGK, Ouwehand WH. Detection of human monocyte-reactive alloantibodies by flow cytometry after selective downmodulation of the Fc receptor I. Blood 1991; 78: 2150-6.
16. Dooren MC, Kuijpers RWAM, Joekes EC, Huiskes E, Goldschmeding R, Overbeeke MAM et al. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR). Lancet 1992; 339: 1067-70.
17. Gottvall T, Selbing A, Hilden JO. Evaluation of a new Swedish protocol for alloimmunization screening during pregnancy. Acta Obstet Gynecol Scand 1993; 72: 434-8.
18. Judd WJ, Luban NL, Ness PM, Silberstein LE, Stroup M, Widmann FK. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient. Transfusion 1990; 30: 175-83.
19. Neppert J, Kissel K. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies. Lancet 1992; 339: 1481.
20. Mollison PL. Results of tests with different cellular bioassays in relation to severity of RhD haemolytic disease. Vox Sang 1991; 60: 225-9.